Citation Tools
PDFPublic health ethics
Paper
Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Eliminating latent tuberculosis in low-burden settings: are the principal beneficiaries to be disadvantaged groups or the broader population?
Other content recommended for you
- A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol
- Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea
- Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis
- Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)
- Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
- Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study
- Risk of active tuberculosis in migrants diagnosed with cancer: a retrospective cohort study in British Columbia, Canada
- Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
- Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study
- Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial